Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FUTURE-GB Trial (Functional and Ultrasound-guided Resection of Glioblastoma) A 2-Stage Trial. A Learning Phase Evaluation of Participating Centres, Followed by a Randomised, Controlled Multicentre Phase III Trial.

NCT05399524 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT05399524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05399524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FUTURE-GB Trial (Functional and Ultrasound-guided Resection of Glioblastoma) A 2-Stage Trial. A Learning Phase Evaluation of Participating Centres, Followed by a Randomised, Controlled Multicentre Phase III Trial.
Lead sponsor
University of Oxford
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2020
Completion date
November 30, 2025
Enrollment
357 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

glioma glioblastoma multiforme